Literature DB >> 10417137

Cytotoxic T-cell-mediated response against Yersinia pseudotuberculosis in HLA-B27 transgenic rat.

G Falgarone1, H S Blanchard, B Riot, M Simonet, M Breban.   

Abstract

Yersinia-induced reactive arthritis is highly associated with HLA-B27, the role of which in defense against the triggering bacteria remains unclear. The aim of this study was to examine the capacity of rats transgenic for HLA-B27 to mount a cytotoxic T-lymphocyte (CTL) response against Y. pseudotuberculosis and to determine the influence of the HLA-B27 transgene on this response. Rats transgenic for HLA-B*2705 and human beta(2)-microglobulin of the 21-4L line, which do not spontaneously develop disease, and nontransgenic syngeneic Lewis (LEW) rats were infected with Y. pseudotuberculosis. Lymph node cells were restimulated in vitro, and the presence of for Y. pseudotuberculosis-specific CTLs against infected targets was determined. Infection of 21-4L rats triggered a CD8(+) T cell-mediated cytotoxic response specific for Y. pseudotuberculosis. Analysis of this response demonstrated restriction by an endogenous major histocompatibility complex molecule. However, no restriction by HLA-B27 was detected. In addition, kinetics studies revealed a weaker anti-Yersinia CTL response in 21-4L rats than in nontransgenic LEW rats, and the level of cytotoxicity against 21-4L lymphoblast targets sensitized with Y. pseudotuberculosis was lower than that against nontransgenic LEW targets. We conclude that HLA-B27 transgenic rats mount a CTL response against Y. pseudotuberculosis that is not restricted by HLA-B27. Yet, HLA-B27 exerts a negative effect on the level of this response, which could contribute to impaired defense against Yersinia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10417137      PMCID: PMC96653     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  56 in total

Review 1.  A new foreign policy: MHC class I molecules monitor the outside world.

Authors:  K L Rock
Journal:  Immunol Today       Date:  1996-03

Review 2.  Yersinia proteins that target host cell signaling pathways.

Authors:  M Fällman; C Persson; H Wolf-Watz
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

3.  Characterization of the synovial T cell response to various recombinant Yersinia antigens in Yersinia enterocolitica-triggered reactive arthritis. Heat-shock protein 60 drives a major immune response.

Authors:  A K Mertz; S Ugrinovic; R Lauster; P Wu; M Grolms; U Böttcher; H Appel; Z Yin; E Schiltz; S Batsford; C Schauer-Petrowski; J Braun; A Distler; J Sieper
Journal:  Arthritis Rheum       Date:  1998-02

4.  HL-A 27 in reactive arthritis. A study of Yersinia arthritis and Reiter's disease.

Authors:  K Aho; P Ahvonen; A Lassus; K Sievers; A Tiilikainen
Journal:  Arthritis Rheum       Date:  1974 Sep-Oct

5.  Temperature-inducible outer membrane protein of Yersinia pseudotuberculosis and Yersinia enterocolitica is associated with the virulence plasmid.

Authors:  I Bölin; L Norlander; H Wolf-Watz
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

6.  A single nonamer from the Yersinia 60-kDa heat shock protein is the target of HLA-B27-restricted CTL response in Yersinia-induced reactive arthritis.

Authors:  S Ugrinovic; A Mertz; P Wu; J Braun; J Sieper
Journal:  J Immunol       Date:  1997-12-01       Impact factor: 5.422

7.  Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies.

Authors:  F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

8.  Coordinate involvement of invasin and Yop proteins in a Yersinia pseudotuberculosis-specific class I-restricted cytotoxic T cell-mediated response.

Authors:  G Falgarone; H S Blanchard; F Virecoulon; M Simonet; M Breban
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

9.  Alteration of HLA-B27 peptide presentation after infection of transfected murine L cells by Shigella flexneri.

Authors:  F Boisgérault; J Mounier; V Tieng; M C Stolzenberg; I Khalil-Daher; M Schmid; P Sansonetti; D Charron; A Toubert
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

10.  HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis.

Authors:  E Hermann; D T Yu; K H Meyer zum Büschenfelde; B Fleischer
Journal:  Lancet       Date:  1993-09-11       Impact factor: 79.321

View more
  4 in total

1.  Animal models of the spondyloarthropathies.

Authors:  M Breban; G Falgarone; H Blanchard; E Dernis-Labous; D Lamarque
Journal:  Curr Rheumatol Rep       Date:  2000-08       Impact factor: 4.592

Review 2.  Pathogenesis of reactive arthritis.

Authors:  J Sieper
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.592

3.  The Yersinia enterocolitica invasin protein promotes major histocompatibility complex class I- and class II-restricted T-cell responses.

Authors:  O T Bühler; C A Wiedig; Y Schmid; G A Grassl; E Bohn; I B Autenrieth
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

4.  Association between polymorphism of the vitamin D metabolism gene CYP27B1 and HLA-B27-associated uveitis. Is a state of relative immunodeficiency pathogenic in HLA B27-positive uveitis?

Authors:  Gernot Steinwender; Ewald Lindner; Martin Weger; Sophie Plainer; Wilfried Renner; Navid Ardjomand; Yosuf El-Shabrawi
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.